![Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response | Science Advances Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response | Science Advances](https://www.science.org/cms/asset/e1c9882b-fa18-436f-8d3b-77c1d5a5b208/abc7112-f1.gif)
Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response | Science Advances
![Perinatal exposure to BDE-47 exacerbated autistic-like behaviors and impairments of dendritic development in a valproic acid-induced rat model of autism - ScienceDirect Perinatal exposure to BDE-47 exacerbated autistic-like behaviors and impairments of dendritic development in a valproic acid-induced rat model of autism - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0147651321001111-gr3.jpg)
Perinatal exposure to BDE-47 exacerbated autistic-like behaviors and impairments of dendritic development in a valproic acid-induced rat model of autism - ScienceDirect
Full article: Exploring the structural transition mechanisms of a pair of poly(N-isopropylacrylamide) chains in aqueous solution through coarse-grained molecular simulations coupled with metadynamics
![Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions | Nature Communications Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-12355-7/MediaObjects/41467_2019_12355_Fig1_HTML.png)
Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions | Nature Communications
![IJMS | Free Full-Text | The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm IJMS | Free Full-Text | The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm](https://www.mdpi.com/ijms/ijms-22-00075/article_deploy/html/images/ijms-22-00075-g001.png)
IJMS | Free Full-Text | The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm
![Applied Sciences | Free Full-Text | A GIS-Based Spatial Analysis Model Approach for Identification of Optimal Hydrotechnical Solutions for Gully Erosion Stabilization. Case Study Applied Sciences | Free Full-Text | A GIS-Based Spatial Analysis Model Approach for Identification of Optimal Hydrotechnical Solutions for Gully Erosion Stabilization. Case Study](https://www.mdpi.com/applsci/applsci-11-04847/article_deploy/html/images/applsci-11-04847-g001.png)
Applied Sciences | Free Full-Text | A GIS-Based Spatial Analysis Model Approach for Identification of Optimal Hydrotechnical Solutions for Gully Erosion Stabilization. Case Study
![Venoarterial Extracorporeal Membrane Oxygenation in High-Risk Pulmonary Embolism: A Case Series and Literature Review Venoarterial Extracorporeal Membrane Oxygenation in High-Risk Pulmonary Embolism: A Case Series and Literature Review](https://article.imrpress.com/journal/RCM/23/6/10.31083/j.rcm2306193/2153-8174-23-6-193/fig1.jpg)
Venoarterial Extracorporeal Membrane Oxygenation in High-Risk Pulmonary Embolism: A Case Series and Literature Review
![IJMS | Free Full-Text | Deciphering GRINA/Lifeguard1: Nuclear Location, Ca2+ Homeostasis and Vesicle Transport IJMS | Free Full-Text | Deciphering GRINA/Lifeguard1: Nuclear Location, Ca2+ Homeostasis and Vesicle Transport](https://www.mdpi.com/ijms/ijms-20-04005/article_deploy/html/images/ijms-20-04005-g001.png)
IJMS | Free Full-Text | Deciphering GRINA/Lifeguard1: Nuclear Location, Ca2+ Homeostasis and Vesicle Transport
![The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2019.2525.abstracts/asset/images/medium/inline1.gif)
The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics
E 10 I.- 81 I i o o (08 I „,, A 71 3/ f 1 o o _ ,2 I , „ , 13 1 4 89 / t o 1 , ; „, ,„ , , 1 A , A , Al 1 , i ,9 19 1 1
![SOLVED: Chtt 34) rlat Timc ( m) Paz ! Vl ( vd 1 54i ( 4) Vu() LeG Le 0,90 0.36 0+61 0.9 0.5 478 0 €8 0.4" stt Cumac( ( 4) SOLVED: Chtt 34) rlat Timc ( m) Paz ! Vl ( vd 1 54i ( 4) Vu() LeG Le 0,90 0.36 0+61 0.9 0.5 478 0 €8 0.4" stt Cumac( ( 4)](https://cdn.numerade.com/ask_images/132814dba23e4eb796151075ee2eed52.jpg)